MARKET

APUS

APUS

APIMEDS PHARMACEUTICALS US INC
AMEX
1.310
+0.030
+2.34%
After Hours: 1.269 -0.041 -3.15% 19:43 06/09 EDT
OPEN
1.100
PREV CLOSE
1.280
HIGH
1.360
LOW
1.100
VOLUME
28.71K
TURNOVER
--
52 WEEK HIGH
5.97
52 WEEK LOW
0.9510
MARKET CAP
19.77M
P/E (TTM)
-2.3753
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at APUS last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at APUS last week (0525-0529)?
Weekly Report · 06/01 09:43
Apimeds Pharmaceuticals Q1 EPS $(2.26) Down From $(0.50) YoY
Benzinga · 05/26 21:32
Weekly Report: what happened at APUS last week (0518-0522)?
Weekly Report · 05/25 09:45
Weekly Report: what happened at APUS last week (0511-0515)?
Weekly Report · 05/18 09:45
Apimeds Pharmaceuticals Delays Quarterly SEC Filing
TipRanks · 05/15 23:34
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 05/11 12:06
Weekly Report: what happened at APUS last week (0504-0508)?
Weekly Report · 05/11 09:43
More
About APUS
Apimeds Pharmaceuticals US, Inc., is a clinical-stage biopharmaceutical company. The Company is engaged in developing Apitox, an intradermally administered bee venom-based toxin. It is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.

Webull offers Apimeds Pharmaceuticals US, Inc. stock information, including AMEX: APUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APUS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading APUS stock methods without spending real money on the virtual paper trading platform.